Literature DB >> 21145510

Soft-tissue tumor differentiation using 3D power Doppler ultrasonography with echo-contrast medium injection.

Hong-Jen Chiou1, Yi-Hong Chou, Wei-Ming Chen, Winby Chen, Hsin-Kai Wang, Cheng-Yen Chang.   

Abstract

BACKGROUND: We aimed to evaluate the ability of 3-dimensional power Doppler ultrasonography to differentiate soft-tissue masses from blood flow and vascularization with contrast medium.
METHODS: Twenty-five patients (mean age, 44.1 years; range, 12-77 years) with a palpable mass were enrolled in this study. Volume data were acquired using linear and convex 3-dimensional probes and contrast medium injected manually by bolus. Data were stored and traced slice by slice for 12 slices. All patients were scanned by the same senior sonologist. The vascular index (VI), flow index (FI), and vascular-flow index (VFI) were automatically calculated after the tumor was completely traced. All tumors were later confirmed by pathology.
RESULTS: The study included 8 benign (mean, 36.5 mL; range, 2.4-124 mL) and 17 malignant (mean, 319.4 mL; range, 9.9-1,179.6 mL) tumors. Before contrast medium injection, mean VI, FI and VFI were, respectively, 3.22, 32.26 and 1.07 in benign tumors, and 1.97, 29.33 and 0.67 in malignant tumors. After contrast medium injection, they were, respectively, 20.85, 37.33 and 8.52 in benign tumors, and 40.12, 41.21 and 17.77 in malignant tumors. The mean differences between with and without contrast injection for VI, FI and VFI were, respectively, 17.63, 5.07 and 7.45 in benign tumors, and 38.15, 11.88 and 16.55 in malignant tumors. Tumor volume, VI, FI and VFI were not significantly different between benign and malignant tumors before and after echo-contrast medium injection. However, VI, FI and VFI under self-differentiation (differences between with and without contrast injection) were significantly different between malignant and benign tumors.
CONCLUSION: Three-dimensional power Doppler ultrasound is a valuable tool for differential diagnosis of soft-tissue tumors, especially with the injection of an echo-contrast medium.
Copyright © 2010 Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145510     DOI: 10.1016/S1726-4901(10)70137-4

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

1.  Differential diagnosis between benign and malignant soft tissue tumors utilizing ultrasound parameters.

Authors:  Takeshi Morii; Tomonori Kishino; Naoko Shimamori; Mitsue Motohashi; Hiroaki Ohnishi; Keita Honya; Takayuki Aoyagi; Takashi Tajima; Shoichi Ichimura
Journal:  J Med Ultrason (2001)       Date:  2017-06-20       Impact factor: 1.314

2.  Doppler ultrasound for diagnosis of soft tissue sarcoma: efficacy of ultrasound-based screening score.

Authors:  Satoshi Nagano; Yuhei Yahiro; Masahiro Yokouchi; Takao Setoguchi; Yasuhiro Ishidou; Hiromi Sasaki; Hirofumi Shimada; Ichiro Kawamura; Setsuro Komiya
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

3.  Small Subcutaneous Soft Tissue Tumors (<5 cm) Can Be Sarcomas and Contrast-Enhanced Ultrasound (CEUS) Is Useful to Identify Potentially Malignant Masses.

Authors:  Armanda De Marchi; Simona Pozza; Lorena Charrier; Filadelfo Cannone; Franco Cavallo; Alessandra Linari; Raimondo Piana; Irene Geniò; Paolo Balocco; Alessandro Massè
Journal:  Int J Environ Res Public Health       Date:  2020-11-28       Impact factor: 3.390

4.  Quantitative assessment of intraneural vascular alterations in peripheral nerve trauma using high-resolution neurosonography: technical note.

Authors:  Patrick Dömer; Ulrike Janssen-Bienhold; Bettina Kewitz; Thomas Kretschmer; Christian Heinen
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

5.  Preoperative Ultrasonographic Evaluation for Malignancy of Soft-Tissue Sarcoma: A Retrospective Study.

Authors:  Takeshi Morii; Tomonori Kishino; Naoko Shimamori; Mitsue Motohashi; Hiroaki Ohnishi; Keita Honya; Takayuki Aoyagi; Takashi Tajima; Shoichi Ichimura
Journal:  Open Orthop J       Date:  2018-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.